Skip to main content
Clinical Trials/CTRI/2024/10/075508
CTRI/2024/10/075508CompletedPhase 2

A placebo controlled trial on the effectiveness of constitutional Homoeopathic medicine in the treatment of Alzheimer Disease with aided therapy

Shivani Sharma1 site in 1 country80 target enrollmentStarted: December 2, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
ADAS-COG Score will be used to assess the sample.

Study Overview

Brief Summary

This study investigates the potential effectiveness of homoeopathy in managing Alzheimer’s disease(AD), a challenging neurodegenerative disorder with limited treatment options. Key findings suggest that homoeopathy may offer promise in alleviating cognitive decline, memory impairment, and behavioural symptoms associated with AD, while also improving overall quality of life for patients. However, the abstract acknowledges limitations in the current body of evidence, such as small sample sizes, heterogeneity of interventions, and methodological flaws in study designs. Despite these challenges, the study underscores the importance of further research to better understand the potential benefits and limitations of homoeopathy in AD management. The findings aim to contribute on the ongoing discourse surrounding integrative approaches to neurodegenerative diseases and inform future clinical practice and research endeavours in this field.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
45.00 Year(s) to 85.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Clinically diagnosed cases of Alzheimer’s Disease with aided therapy.
  • Follow up of atleast 3 months will be considered in the study.
  • Who agreed to give consent for the study.

Exclusion Criteria

  • Patients with systemic disorder.
  • Subjects with other psychiatric disorders.
  • (namely panic disorder, Agoraphobia, specific phobia, social phobia, post-traumatic stress disorder and obsessive compulsive disorder)
  • Any case of accident, poison, or drug reaction.
  • Patient unable to empty with regular follow ups.

Outcomes

Primary Outcomes

ADAS-COG Score will be used to assess the sample.

Time Frame: follow up after every 1 month

Secondary Outcomes

  • To find out the more efficacious homeopathic medicine(1 year)

Investigators

Sponsor
Shivani Sharma
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Shivani Sharma

Sri Ganganagar Homeopathic Medical College Hospital And Research Institute

Study Sites (1)

Loading locations...

Similar Trials